{"log_id": 8255968583533605340, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 7e-05, "average": 0.995865, "min": 0.958839}, "location": {"width": 833, "top": 181, "height": 55, "left": 185}, "words": "流涎、呕吐白色泡沫状物、共济失调、震颤、活动减少和或弓背姿势。但这些"}, {"probability": {"variance": 1e-06, "average": 0.999258, "min": 0.99646}, "location": {"width": 832, "top": 229, "height": 53, "left": 188}, "words": "症状都是一过性的、轻微的,且随着试验的继续进行事件的发生率有所降低。另"}, {"probability": {"variance": 0.007437, "average": 0.977839, "min": 0.590395}, "location": {"width": 829, "top": 278, "height": 51, "left": 189}, "words": "外,在毒性试验的第14-27周,通过对组织结构的观察发现:50mg/kg/天剂量组"}, {"probability": {"variance": 5e-05, "average": 0.997346, "min": 0.958082}, "location": {"width": 833, "top": 325, "height": 52, "left": 190}, "words": "动物存在极轻微到轻度的骨骼肌变性。然而在毒性研究进行到53周时这种骨骼"}, {"probability": {"variance": 6e-06, "average": 0.998608, "min": 0.987928}, "location": {"width": 832, "top": 374, "height": 51, "left": 191}, "words": "肌变性就观察不到了,这说明随着治疗的持续这种变性没有再次出现或进展。在"}, {"probability": {"variance": 0.001805, "average": 0.988809, "min": 0.739971}, "location": {"width": 828, "top": 421, "height": 54, "left": 195}, "words": "犬中50mg/kg/天的药物剂量大约为成年推荐每日用量100mg的26倍。大鼠口服"}, {"probability": {"variance": 0.000264, "average": 0.994257, "min": 0.905666}, "location": {"width": 833, "top": 469, "height": 53, "left": 194}, "words": "最高剂量达到180mg/kg天(最高达人体暴露量的23倍,按成人日推荐剂量"}, {"probability": {"variance": 0.001261, "average": 0.98862, "min": 0.810663}, "location": {"width": 826, "top": 516, "height": 52, "left": 201}, "words": "100mg/天计)时,没有观察到显著的毒性。可以观察到的药物相关的不良反应仅"}, {"probability": {"variance": 0.003765, "average": 0.984097, "min": 0.600237}, "location": {"width": 832, "top": 564, "height": 50, "left": 197}, "words": "有服药后流涎,这可能与剂量达到60mg/kg天和180mg/kg/天时对药物的口感下"}, {"probability": {"variance": 0, "average": 0.999671, "min": 0.999189}, "location": {"width": 77, "top": 630, "height": 30, "left": 199}, "words": "降有关"}, {"probability": {"variance": 0.000163, "average": 0.996627, "min": 0.92283}, "location": {"width": 832, "top": 657, "height": 51, "left": 200}, "words": "目前考虑这些在动物身上观察到的治疗相关的改变,对于服用推荐治疗剂量的人"}, {"probability": {"variance": 6e-06, "average": 0.997965, "min": 0.991742}, "location": {"width": 267, "top": 719, "height": 36, "left": 202}, "words": "类而言没有任何临床意义"}, {"probability": {"variance": 2.5e-05, "average": 0.995924, "min": 0.988923}, "location": {"width": 76, "top": 814, "height": 28, "left": 207}, "words": "致癌性"}, {"probability": {"variance": 1e-05, "average": 0.99733, "min": 0.991021}, "location": {"width": 145, "top": 860, "height": 28, "left": 211}, "words": "磷酸西格列汀"}, {"probability": {"variance": 0.002731, "average": 0.8582, "min": 0.805943}, "location": {"width": 59, "top": 857, "height": 36, "left": 888}, "words": "药经"}, {"probability": {"variance": 0.009858, "average": 0.965395, "min": 0.552489}, "location": {"width": 827, "top": 889, "height": 50, "left": 208}, "words": "在雄性和雌性大鼠中进行了为期两年的口服西格列汀50mgkg天、150mg/g天"}, {"probability": {"variance": 0.00167, "average": 0.987894, "min": 0.757026}, "location": {"width": 826, "top": 937, "height": 51, "left": 209}, "words": "和500mg/kg/天的致癌性研究。研究观察到高剂量雄性大鼠的肝脏腺瘤和肝癌的"}, {"probability": {"variance": 5e-06, "average": 0.998275, "min": 0.9907}, "location": {"width": 805, "top": 984, "height": 49, "left": 209}, "words": "发生率增高,高剂量雌性大鼠的肝癌发生率增高。基于成人的推荐剂量为100m"}, {"probability": {"variance": 0.011991, "average": 0.971903, "min": 0.41103}, "location": {"width": 824, "top": 1031, "height": 50, "left": 211}, "words": "天,大鼠的这一剂量大约为人体暴露量的58倍。在大鼠中这一剂量水平与肝"}, {"probability": {"variance": 0.00012, "average": 0.994585, "min": 0.950295}, "location": {"width": 830, "top": 1080, "height": 46, "left": 211}, "words": "中毒密切相关。当药物剂量≤150mg/kg天时没有观察到肝脏肿瘤形成,这一剂"}, {"probability": {"variance": 0.001091, "average": 0.991672, "min": 0.797319}, "location": {"width": 824, "top": 1126, "height": 46, "left": 213}, "words": "量大约为人体暴露量的19倍(按100mg的推荐剂量计)。已发现大鼠体内的肝"}, {"probability": {"variance": 6.7e-05, "average": 0.997077, "min": 0.955201}, "location": {"width": 829, "top": 1174, "height": 43, "left": 213}, "words": "脏毒性与肝脏肿瘤的形成有关,所以这一高剂量引发的慢性肝脏毒性会继发引起"}, {"probability": {"variance": 2.7e-05, "average": 0.997822, "min": 0.971957}, "location": {"width": 717, "top": 1224, "height": 41, "left": 214}, "words": "大鼠肝脏肿瘤发生率的增高。尚不清楚上述结果对于人类的临床意义"}, {"probability": {"variance": 0.001324, "average": 0.992632, "min": 0.777612}, "location": {"width": 805, "top": 1270, "height": 42, "left": 216}, "words": "另一项为期两年的致癌性试验中,雄性和雌性小鼠分别口服了50mg/kg/天"}, {"probability": {"variance": 0.010936, "average": 0.965792, "min": 0.502018}, "location": {"width": 822, "top": 1313, "height": 52, "left": 223}, "words": "25mgkg/天、250mgkg/天和500mg/kg天剂量的西格列汀。试验结果显示:药"}, {"probability": {"variance": 0.004421, "average": 0.98193, "min": 0.604101}, "location": {"width": 824, "top": 1363, "height": 43, "left": 217}, "words": "物剂量低于500mg/kg/天(相当于68倍的人体暴露量,基于成人推荐剂量100mg"}, {"probability": {"variance": 3e-05, "average": 0.997213, "min": 0.978611}, "location": {"width": 572, "top": 1414, "height": 39, "left": 219}, "words": "天)时,西格列汀并不增加小鼠任何器官肿瘤的发生率"}, {"probability": {"variance": 0.005814, "average": 0.957239, "min": 0.788092}, "location": {"width": 148, "top": 1508, "height": 34, "left": 221}, "words": "盐酸二甲双胍"}, {"probability": {"variance": 5.9e-05, "average": 0.996283, "min": 0.958296}, "location": {"width": 801, "top": 1546, "height": 42, "left": 220}, "words": "以大鼠(治疗持续104周)和小鼠(治疗持续91周)为研究对象的动物试验"}], "language": 3}